Hematologic Cancer

These guidelines and other documents provide advice for different types of hematologic cancer: non-Hodgkin lymphoma, leukemia, multiple myeloma, Hodgkin lymphoma, myelodysplastic syndrome (MDS) and myelofibrosis.

CAR T-cell Therapy Enrolment

Displaying Guidelines

51 articles

Acute Leukemia Provincial Plan

Document Status: Current
ID: GL-C50-34

Aug 2017

Adult Acute Leukemia Services Plan for the Greater Toronto Area - Recommendations Report

Document Status: Current
ID: GL-C50-02

Jan 2012

Alemtuzumab for the Treatment of T-cell Prolymphocytic Leukemia

Document Status: Archived
ID: 6-22

Jan 2007

Alemtuzumab in Chronic Lymphocytic Leukemia

Document Status: Education and Information
ID: 6-16 Version 2
Version: 2

Feb 2014

An Endorsement of the 2022 NCCN Guideline on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Document Status: Current
ID: GL-END-C50-35

Aug 2023

Best Practices for Pathology Secondary Review: Hematologic Cancers

Document Status: Archived
ID: 22-2-6

Jun 2014

Bortezomib in Multiple Myeloma and Lymphoma

Document Status: Archived
ID: 6-18
Version: 2

Jun 2016

Complex Malignant Hematology Models of Care: Recommendations for Changes in the Roles and Composition of the Multidisciplinary Team and the Setting of Care to Improve Access for Patients in Ontario – March 2017

Document Status: Current
ID: GL-C50-31

Mar 2017

Consensus Diagnostic and Prognostic Testing for Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: Recommendations Report - 2024

Document Status: Current
Version: 1.0

Updated

Jan 2024

Consensus Pathology Recommendations for Complex Malignant Hematology – December 2016

Document Status: Current
ID: GL-C50-28

Dec 2016

Dasatinib for the Treatment of Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

Document Status: Archived
ID: 6-23 (CED)

Jan 2012

Extra-corporeal Photopheresis in the Management of Graft-Versus-Host Disease in Patients who Have Received Allogeneic Blood or Bone Marrow Transplants: Recommendations

Document Status: Current
ID: SCT 5

Aug 2013